Alpine Global Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Alpine Global Management’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,000	Closed	-$2.04M	–	517
2024 Q2	$2.04M	Buy	+50,000	New	+$2.08M	0.36%	60

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Alpine Global Management's CERE Position: Q3 2024 in Review

Alpine Global Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 50,000 shares — an estimated $2.04M sold.

Alpine Global Management first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $2.04M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Alpine Global Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Alpine Global Management sold 50,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $2.04M.
Alpine Global Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Alpine Global Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2.04M in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.